LENZ Therapeutics, Inc.: LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates

Launched VIZZ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net pr ...
Engineering News

Unlocking Investment to Close Africa’s Energy Gap

Africa stands at a critical crossroads in its energy journey. Despite being home to some of the world’s fastest-growing ...

Toll Brothers, Inc.: Toll Brothers Announces Chairman and CEO Doug Yearley to Become Executive Chairman; Karl Mistry to Succeed Yearley as Chief Executive Officer

Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation's leading builder of luxury homes, today announced that, as part of its long-term ...
Retail Design Blog

Teshima Factory by Schemata Architects + Jo Nagasaka

Teshima Factory is a project that revitalised a former ironworks located in front of Ieura Port in Teshima Island as a ...
Santé log

Basilea provides portfolio update and outlook

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...